Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Assets Average (2016 - 2026)

Standard Biotools has reported Assets Average over the past 15 years, most recently at $553.7 million for Q4 2025.

  • Quarterly Assets Average fell 14.41% to $553.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $553.7 million through Dec 2025, down 14.41% year-over-year, with the annual reading at $590.0 million for FY2025, 26.16% up from the prior year.
  • Assets Average was $553.7 million for Q4 2025 at Standard Biotools, up from $548.3 million in the prior quarter.
  • Over five years, Assets Average peaked at $743.2 million in Q2 2024 and troughed at $273.6 million in Q1 2022.
  • The 5-year median for Assets Average is $391.8 million (2022), against an average of $448.1 million.
  • Year-over-year, Assets Average surged 104.32% in 2024 and then dropped 23.54% in 2025.
  • A 5-year view of Assets Average shows it stood at $278.7 million in 2021, then surged by 44.46% to $402.6 million in 2022, then fell by 17.74% to $331.2 million in 2023, then surged by 95.35% to $646.9 million in 2024, then dropped by 14.41% to $553.7 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Assets Average are $553.7 million (Q4 2025), $548.3 million (Q3 2025), and $568.3 million (Q2 2025).